Metagenomi Inc. Common St... (MGX)
Metagenomi Common Stock Statistics
Share Statistics
Metagenomi Common Stock has 37.38M shares outstanding. The number of shares has increased by -0.22% in one year.
| Shares Outstanding | 37.38M |
| Shares Change (YoY) | -0.22% |
| Shares Change (QoQ) | -0.11% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 21.78M |
| Failed to Deliver (FTD) Shares | 8.78K |
| FTD / Avg. Volume | 0.98% |
Short Selling Information
The latest short interest is 2.17M, so 5.79% of the outstanding shares have been sold short.
| Short Interest | 2.17M |
| Short % of Shares Out | 5.79% |
| Short % of Float | 11.54% |
| Short Ratio (days to cover) | 1.89 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -0.96. Metagenomi Common Stock's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -0.96 |
| PS Ratio | 0 |
| Forward PS | 5.2 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Metagenomi Common Stock.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.91, with a Debt / Equity ratio of 0.19.
| Current Ratio | 6.91 |
| Quick Ratio | 6.91 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | -0.55 |
| Debt / FCF | -0.41 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $258.89K |
| Profits Per Employee | $-386.43K |
| Employee Count | 202 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.51M |
| Effective Tax Rate | 6.6% |
Stock Price Statistics
The stock price has increased by -85.28% in the last 52 weeks. The beta is -0.27, so Metagenomi Common Stock's price volatility has been lower than the market average.
| Beta | -0.27 |
| 52-Week Price Change | -85.28% |
| 50-Day Moving Average | 2 |
| 200-Day Moving Average | 2.73 |
| Relative Strength Index (RSI) | 35.09 |
| Average Volume (20 Days) | 894.18K |
Income Statement
In the last 12 months, Metagenomi Common Stock had revenue of 52.3M and earned -78.06M in profits. Earnings per share was 0.
| Revenue | 52.3M |
| Gross Profit | 52.3M |
| Operating Income | -88.9M |
| Net Income | -78.06M |
| EBITDA | -83.49M |
| EBIT | -88.9M |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 27.39M in cash and 45.78M in debt, giving a net cash position of -18.39M.
| Cash & Cash Equivalents | 27.39M |
| Total Debt | 45.78M |
| Net Cash | -18.39M |
| Retained Earnings | -223M |
| Total Assets | 324.6M |
| Working Capital | 220.65M |
Cash Flow
In the last 12 months, operating cash flow was -109.07M and capital expenditures -3.11M, giving a free cash flow of -112.19M.
| Operating Cash Flow | -109.07M |
| Capital Expenditures | -3.11M |
| Free Cash Flow | -112.19M |
| FCF Per Share | 0 |
Margins
Gross margin is 100%, with operating and profit margins of -170% and -149.26%.
| Gross Margin | 100% |
| Operating Margin | -170% |
| Pretax Margin | -159.81% |
| Profit Margin | -149.26% |
| EBITDA Margin | -159.66% |
| EBIT Margin | -170% |
| FCF Margin | -214.53% |
Dividends & Yields
MGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MGX is $15, which is 979.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $15 |
| Price Target Difference | 979.1% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | -0.54 |
| Piotroski F-Score | 4 |